Quinupristin/dalfopristin (trade name Synercid) is a combination of two antibiotics used to treat infections by staphylococci and by vancomycin-resistant ...
Quinupristin is an antibiotic, often used in combination with dalfopristin under the trade name Synercid. It is active against Gram-positive bacteria, atypical but not ...
Dec 1, 2001 ... Quinupristin-dalfopristin is a streptogramin. This class of antibiotics is an important addition to the options available for the treatment of severe ...
(quinupristin and dalfopristin for injection). One of Synercid's approved indications is for the treatment of patients with serious or life-threatening infections.
Synercid® (quinupristin and dalfopristin powder for injection) I.V., a streptogramin antibacterial agent for intravenous administration, is a sterile lyophilized ...
Medscape - Infection dosing for Synercid (quinupristin/dalfopristin), frequency- based adverse effects, comprehensive interactions, contraindications, pregnancy ...
Jul 6, 2007 ... Dalfopristin inhibits the early phase of protein synthesis in the bacterial ribosome and quinupristin inhibits the late phase of protein synthesis.
Easy to read patient leaflet for quinupristin/dalfopristin. Includes indications, proper use, special instructions, precautions, and possible side effects.
Quinupristin/dalfopristin (Synercid, Rhone-Poulenc Rorer, Collegeville, Penn) is a member of the macrolide-lincosamide-streptogramin class of antibiotics.
Venous irritation due to quinupristin/dalfopristin is common. In comparative trials approximately 40% of patients experienced infusion site adverse reactions ...